September 2025 • PharmaTimes Magazine • 15
// THOUGHT LEADER //
Centre stage
Survey reveals lack of awareness, need for greater clarity and desire for more education about breast cancer
A new survey reveals a troubling reality: most Western Europeans feel under-informed about breast cancer.1 88% of Europeans say they want better information about the disease, signalling not only a lack of awareness but also an urgent need to reshape how breast cancer is discussed and understood.
The survey, initiated and funded by Daiichi Sankyo and AstraZeneca, gathered responses from 7,750 people in France, Germany, Italy, Spain and the UK, aimed to assess public knowledge around breast cancer, and identify educational gaps to shape future care and communication efforts.
Despite the high visibility of breast cancer awareness campaigns, many remain unclear on key facts about the disease. From early detection and treatment options to understanding metastatic breast cancer, the findings suggest that current awareness efforts are not going far enough.
Whether due to stigma, misinformation, or limited access to reliable resources, the demand for accurate, accessible education on breast cancer is stronger than ever.
Key findings:
1. A lack of readily available information
88% of respondents expressed a desire for more information about breast cancer, highlighting the pressing need for accessible and engaging educational resources to bridge the information gap.1 43% pointed to a critical issue – the complexity of existing medical information on breast cancer – illustrating a need for clearer, more digestible content that allows for enhanced patient understanding of the disease.1
2. Misinformation remains widespread
Misconceptions and knowledge gaps continue to limit efforts to advance disease awareness. Many are unaware that age significantly affects breast cancer risk, leading to potential delays in seeking screening or medical attention, which can postpone diagnosis and treatment.
Moreover, a surprising number of people believe that breast cancer is a challenge we have already overcome.1 Reducing the stigma and myths associated with the disease can help individuals recognize early signs and symptoms, leading to earlier diagnosis and improved treatment outcomes.
3. Biomarker awareness is limited
Respondents expressed a strong interest in obtaining information about new treatment methods in breast cancer care.
A key aspect of this effort involves demystifying cancer biomarkers, which play a pivotal role in personalised treatment plans, enhancing patient outcomes and quality of life.3 Yet, despite their central role in cancer management, a striking three-quarters of survey respondents admitted to being unfamiliar with the very concept of a biomarker.1
“It’s time to encourage a change in breast cancer awareness and education. By addressing misconceptions and making information more accessible, we can support individuals in taking proactive steps in managing their health, ultimately improving lives and the well-being of those affected by this difficult disease.”
Markus Kosch Head of Oncology, Europe and Canada, at Daiichi Sankyo
References: